These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 2475852
1. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials. Nissen-Druey C. Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852 [No Abstract] [Full Text] [Related]
2. The promise of colony-stimulating factors in clinical practice. Glaspy JA, Ambersley JM. Oncol Nurs Forum; 1990; 17(1 Suppl):20-4. PubMed ID: 1689043 [Abstract] [Full Text] [Related]
3. Therapeutic administration of recombinant human granulocyte colony-stimulating factor accelerates hemopoietic regeneration and enhances survival in a murine model of radiation-induced myelosuppression. Patchen ML, MacVittie TJ, Solberg BD, Souza LM. Int J Cell Cloning; 1990 Mar; 8(2):107-22. PubMed ID: 1690250 [Abstract] [Full Text] [Related]
8. Hematopoietic growth factors in bone marrow transplantation for hematologic malignancies. Lazarus HM. Prog Clin Biol Res; 1990 Sep; 352():531-8. PubMed ID: 1698303 [No Abstract] [Full Text] [Related]
9. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure. Antin JH, Smith BR, Holmes W, David RN, Rosenthal S. Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331 [Abstract] [Full Text] [Related]
10. Differential effect of GM-CSF and G-CSF in cyclic neutropenia. Freund MR, Luft S, Schöber C, Heussner P, Schrezenmaier H, Porzsolt F, Welte K. Lancet; 1990 Aug 04; 336(8710):313. PubMed ID: 1695985 [No Abstract] [Full Text] [Related]
11. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease. Devereaux S, Linch DC, Gribben JG, McMillan A, Patterson K, Goldstone AH. Bone Marrow Transplant; 1989 Jan 04; 4(1):49-54. PubMed ID: 2647187 [Abstract] [Full Text] [Related]
12. [Application of CSF to cancer treatment]. Takaku F. Gan To Kagaku Ryoho; 1988 Apr 04; 15(4 Pt 2-1):739-46. PubMed ID: 2455478 [Abstract] [Full Text] [Related]
13. [GM-CSF: its clinical administration; the treatment of aplasia]. Rossi Ferrini P, Grossi A, Santini V, Vannucchi AM. Haematologica; 1989 Oct 04; 74(5 Suppl):489-500. PubMed ID: 2512231 [No Abstract] [Full Text] [Related]
14. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation. Klingemann HG, Eaves AC, Barnett MJ, Reece DE, Shepherd JD, Belch AR, Brandwein JM, Langleben A, Koch PA, Phillips GL. Clin Invest Med; 1990 Apr 04; 13(2):77-81. PubMed ID: 2191816 [Abstract] [Full Text] [Related]
17. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation. Barge AJ. Bone Marrow Transplant; 1993 Apr 04; 11 Suppl 2():1-11. PubMed ID: 8334433 [Abstract] [Full Text] [Related]
18. Clinical role of granulocyte-macrophage colony-stimulating factor. Mitsuyasu RT, Golde DW. Hematol Oncol Clin North Am; 1989 Sep 04; 3(3):411-25. PubMed ID: 2698875 [Abstract] [Full Text] [Related]
19. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF. Geissler D, Niederwieser D, Aulitzky WE, Tilg H, Grünewald K, Huber C, Konwalinka G. Behring Inst Mitt; 1988 Aug 04; (83):289-300. PubMed ID: 3071343 [Abstract] [Full Text] [Related]
20. Granulocyte colony-stimulating factors. Med Lett Drugs Ther; 1991 Jun 28; 33(847):61-3. PubMed ID: 1710761 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]